Unearthing Of Antibodies Could Assist The Discovery Of An AIDS Vaccine
July 9th, 2010 - 7:19 pm ICT by Pen Men At WorkJuly 9, 2010 (Pen Men at Work): A study on Science, published this Thursday, has declared that the American scientists have unearthed the most effectual HIV antibodies up to now. These could be utilized to uncover a vaccine for the virus. A squad of researchers was synchronized by the National Institutes of Health (NIH). These researchers detected two proteins that have the capacity to reduce the effect of more than 90% of the recognized international strains of HIV. The aforementioned two antibodies are VRC01 and VRC02. They have the ability to deactivate more strains with larger potency than any other previously acknowledged antibody.
The scientists have understood the manner in which the aforementioned antibodies function and where they connect to the virus. These scientists have now commenced the process of the creation of a possible vaccine. Their labors could be employed in the cure of HIV.
Anthony Fauci happens to occupy the position of the director of the NIH’s National Institute of Allergy and Infectious Diseases. He has asserted that the method employed by the scientists to uncover the fresh antibodies symbolizes an original approach that could be valid to vaccine design for numerous contagious maladies.
There are vaccines that successfully thwart polio and other viral illnesses. The preparation of an AIDS vaccine, which will similarly put a stop to HIV infection, will take several years. Vaccine generation is a pricey affair and also reasonably discouraging since HIV is akin to a moving target, which alters readily.
The process of locating individual antibodies that can deactivate HIV strains is cumbersome as the virus perpetually transforms its surface proteins to dodge identification by the immune structure. This has given rise to a massive number of HIV variants globally.
John Mascola, responsible for heading one of the research squads, has stated that the recently discovered antibodies connect to a nearly motionless area of the virus. Therefore, these antibodies have the wherewithal to defuse such an astonishing assortment of HIV strains.
AIDS plagues approximately 33 million individuals internationally. It has liquidated 25 million persons since the deadly disease commenced in the 1980s. There is no vaccine or therapy. Drugs can facilitate the management of the disease though for some time.
The virus is hard to battle in some measure since it assaults the immune structure cells and also since it changes constantly. It has been roughly unattainable to construct a vaccine that will impinge on the virus. In September 2009, scientists mentioned their largest triumph yet with a vaccine that seemed to slow the speed of infectivity by about 30 percent in Thai helpers. Nonetheless, the trial generated several uncomfortable queries.
- Antibodies that prevent HIV from infecting human cells found - Jul 09, 2010
- Universal influenza vaccine 'on the anvil' - Dec 07, 2010
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Virus-like particle vaccine could offer protection against chikungunya virus - Jan 29, 2010
- One-time jab to protect against all flu strains - Nov 16, 2010
- Promising target for AIDS vaccine identified - Apr 01, 2011
- Scientists devise new strategy to design antibody-based HIV vaccine - Jun 15, 2009
- Vaccine-delivering nanoparticles may help fight HIV, malaria - Feb 23, 2011
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Human trials under way for new HIV vaccine - Jan 03, 2012
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Structure of immune molecule that counteracts HIV strains determined - Jun 02, 2010
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- A Vaginal Gel Represents A Breakthrough In The War Against AIDS - Jul 20, 2010
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
Tags: aids vaccine, american scientists, anthony fauci, antibody, hiv antibodies, hiv infection, hiv strains, hiv variants, infectious diseases, massive number, men at work, moving target, national institute of allergy and infectious diseases, national institutes of health, national institutes of health nih, pen men, strains of hiv, surface proteins, vaccine design, viral illnesses